⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18403049 | 1.00 | — | — | |
| SCHEMBL23375766 | 0.78 | — | — | |
| SCHEMBL22252418 | 0.74 | — | — | |
| SCHEMBL18480752 | 0.74 | — | — | |
| SCHEMBL21187585 | 0.74 | — | — | |
| SCHEMBL23169936 | 0.74 | — | — | |
| SCHEMBL16770486 | 0.74 | — | — | |
| SCHEMBL25561209 | 0.74 | — | — | |
| SCHEMBL18871378 | 0.72 | — | — | |
| SCHEMBL23104655 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230002372-A1 | AZAINDOLE CARBOXAMIDE COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC (US) | 2023-01-05 | — | — | US | disclosed |
| WO-2021062316-A1 | AZAINDOLE CARBOXAMIDE COMPOUNDS FOR THE TREATMENT OF MYCOBACTERIAL INFECTIONS | THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. (US) | 2021-04-01 | — | — | WO | disclosed |
| WO-2020194168-A1 | PROCESS FOR PREPARING HIGHLY PURE TEMOZOLOMIDE | SHIVALIK RASAYAN LIMITED (IN) | 2020-10-01 | — | — | WO | disclosed |